Somatomedin (SM) activity was measured by a placental membrane receptor assay using '"L-LabeIed somatomedin A, as radidigand in serum samples obtained from 33 ovine fetuses, I4 neonatal lambs, 8 pregnant, mnd 3 postpartum ewes. The mean serum concentration o f SM activity i n eight adult rams was 2.06 k 0.12 U/ml. In fetal sheep, SM activity was detected at 66 days gestation (term 147 days), in the youngest fetus studied. Before 100 days o f gestation, SM was lower ( P < 0.001) in fetal sheep (1.M f 0.18 U/ml) than in adult rams. In fetuses between 101 and 125 days, SM rose ( P < 0.001) t o 2.64 & 0.32 U/ml. In late gestation fetal serum SM fell but during the neonatal period it rose t o 3.38 f 0.3 U/ml, higher ( P < 0.01) than that In adult rams. Serum SM activity in the pregnant ewe prior to 100 days was 1.01 k 0.11 U/ml, increased ( P < 0.05) to 1.75 f 0.21 U/ml between 125 days and term, and rose further to 2.56 2 032 U/ml in the postpartum period. Maternal concentrations of serum SM in late gestation were significantly less than in the fetus. Gel chromatography o f fetal, maternal, and neonatal sera indicated that over 90% o f S M activity circulated i n high-mdecular weight form. The rise in SM activity in fetal serum between 100 and 125 days parallels the rise in fetal growth hormone and prolactin concentrations; however, in maternal serum the increase in SM activity i s associated with rising maternal chorionic somatomolmmotropin concentrations.
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Speculation
Somatomedin is present i n fetal ovine serum and i n late gestation may be generated mainly by fetal pituitary hormones. In contrast, somatomedin i n the pregnant ewe appears to be regulated by cborionic somatomammotropln.
Mammalian fetal growth has generally been considered to be independent of fetal pituitary growth hormone (GH) (3, 13, 4) . However, several studies have shown an association in humans bewteen birth size and plasma somatomedin (SM) activity as measured in several assay systems (2, 6, 18) . The present study reports the ontogeny of serum concentrarions of SM activity as determined in a human placental, membrane radioreceptor assay in fetal, and neonatal sheep. The relationship of these concentrations to possible hormonal regulators of SM generation in the fetus and pregnant ewe is discussed.
METHODS
Samples: Samples were obtained from 33 ovine fetuses between 66 days gestation and term (147 days) by cardiac puncture during hysterotomy as previously described (9). Additional serum samples were obtained from 14 lambs and 8 pregnant and 3 postpartum ewes via an indwelling femoral venous catheter, and by jugular puncture from 8 rams at least 2 years of age. The serum was stored at -20" until assay.
Assay Procedure: SM was concentrated from Cohn fraction IV-1 of human plasma (Cutter Laboratories, Berkeley, CA) utilizing acid-ethanol extraction, formic acid extraction and Sephadex gel chromatography (21). Fractions with a Kd value o f 0.3 to 0.5 on Sephadex G-50 chromatography eluted with 0.5 M acetic acid were pooled and purified further by ion exchange chromatography using carboxymethylcellulose (CM-52 Whatman). The sample was applied in 0.1 M NH4Ac, pH 4.0 and eluted over a pH gradient from 4.7 to 6.9. SM activity was determined in eluate by the active fraction that eluted in the most acidic position (pH 5.0 to 5.2) was defined as SM-A1 and was purified further by exclusion chromatography on Sephadex G-SO. This preparation had a receptor assay activity of 1350 U/mg (I unit of SM activity being defined as the activity in a I ml aliquot of pooled serum obtained from 80 adults) and was used as the radiolagand in the human placental membrane receptor assay for somatomedin activity. The SM-A1 was iod~nated by a modification of the lactoperoxidase method (20). The Free iodine was separated from labeled peptides by rechromatography on CM-cellulose as described above.
Particulate membrane fractions from human placentae were prepared and the rad~oreceptor assay for SM activity performed by the procedure of Marshall et a1 (15). A pool of serum from 80 adults was used as a reference standard and was defined as having 1 unit SM activity per ml. Unextracted human and ovine sera displaced ~""SM-AI in a parallel fashion. Because heparinized plasma did not demonstrate consistent parallelism in the assay only serum samples were assayed. The activity measured by the assay demonstrated growth hormone dependence as evidenced by measurements in acromegaly (3.5 * 0.4 U/ml), normal adults (1.06 k 0.04 U/ml), and hypopituitary dwarfism (0.37 f 0.3 U/ ml); the interassay variation was 6% and the minimal detectable dose 0.01 units (16). Each sample was assayed in quadruplicate at a mlnimum of 2 dilutions and any values not fulfilling criteria of parallelism and linearity were rejected.
Gel Filrration Srudies: To assess the relative amount of SM circulating in association with its binding protein, 2 ml serum SOMATOMEDIN IN THE FETUS from selected fetuses, mothers and neonates was applied to Sephadex G-50 (1.5 x 60 cm) in 0.05 M Tris, pH 7.6, and a marker of free IUI was added. Fractions collected between the void volume and the complete elution of albumin, as judged by the OD at 280 nrn, were poled and an aliquot measurd as an estimate of bound SM activity. The eluates which followed until the elution of the marker were pooled separately and an aliquot portion measured for estimation of "free" SM activity.
Slatislics: Regression curves were calculated by computer by the method of least squares. Comparison between groups was by analysis of variance for unequal sized groups. Results are expressed as m a n & SE.
RESULTS
SM activity was detected in all fetal, maternal, and nmnatal sera. The SM activity in 8 adult rams was 2.06 + 0.12 U/ml. The SM activity in fetal and neonatal sheet, is shown in Figures 1 and   2 . Prior to'100 days gestation the SM Soncentration isj.08 * 0.18 U/rnl, lower (p < 0.001) than the SM in adult rams. Between 100 and 125 days, fetal SM activity rose to 2.64 k 0.32 U/ml, higher (p < 0.001) than that in (he younger fetuses. Between 126 and 150 days gestation, SM activity fell (p < 0.01) to 2.09 * 0.1 l U/ml. In the neonate 11-30 days postpartum), SM activity was significantly higher (3.93 * 0.3 U/ml) than in the fetus or adult. In two infant lambs, 60 days postpartum SM activity was comparable to that in the adult ram (i .65,-2.20 U/ml).
SM activity in the ewe is shown in Figure 2 . In pregnant ewes of l a s than 100 days gestation, SM activity was 1.01 & 0. I I. U/ml, lower than in the adult ram @ < 0.001). In pregnant ewes of 101 days to term, SM activity was higher (p c 0.05) at 1.75 2 0.2 1 U/ ml and rose further in the postpartum period (&7 days) to 2.56 2 0.32 U/ml (Fig. 2) . SM activity in the pregnant ewe between 101 and 150 days was less (p < 0.05) than in the fetus (2.32 * 0.1 l U/ml) over a comparable gestational period. Similarly, SM activity in the postpartum ewe was less (p < 0.05) than in the neonatal lamb.
Exclusion chromatography on Sephadex gel at neutral pH of samples of fetal (133 days), maternal (1 16 days) and neonatal (5 days) sera demonstrated no detectable (<Im) SM activity in the low molecular weight range; all activity was recovered in the high molecular weight fractions.
DISCUSSION
In the present study SM activity was detected in the serum of the youngest fetus studied at 66 days gesiation and fetal S M activity increased after 100 days. In the fetal pig, serum SM activity, as measured by the somatomedin C placental membrane receptor assay, has been detected at 24 days gestation (term 115 days) but no correlation between fetal SM concentrations and gestational age was observed (2). In human cord Mood SM activity, as measured by porcine cartilage assay between 24 weeks gestation and term correlates with gestational age (6).
In the neonatal rat (17) and in both the human (2, 6, 18, 19) and porcine fetus (2) SM activity is lower than in the adult. In the present study SM activity in the ovine fetus was lower than in the adult ram prior to 100 days but after this rose to higher concentrations than in either the pregnant ewe or adult ram. This species difference remains unexplained. However, there are also species differences in the fetal plasma concenlrations of growth hormone. In the ovine fetus the mean GH concentration rises during the last trimester whereas falling GH concentrations are observed in the human fetus at a comparable gestational age (7).
A further increase in serum S M activiiy was noted in the neonatal sheep as compared to the late gestation fetus. Tato et a1 (19) reported that in the term newborn human, SM as measured by porcine cartilage bioassay is low in the newborn, rises lo adult concentrations by one week of age, and falls to low concentrations by one month. The explanation of the postnatal rise in SM in both the lamb and ewe is uncertain. Estrogen in vivo has been reported to suppress SM activity (22) and the higher postnatal SM concentrations might reflect "release" from the suppressive activity of . . estrogen during pregnancy.
Somatomedin circulates bound to a high molecular weight binding protein (I 1). In light of the high SM concentrations in the
